Cbl-b-regulated extracellular signal-regulated kinase signaling is involved in the shikonin-induced apoptosis of lung cancer cells in vitro

Experimental and Therapeutic Medicine
Dan QuSheng-Qi Li

Abstract

Shikonin (SK), a naturally occurring naphthoquinone, exhibits antitumor activity. However, its precise mechanisms of action are unknown. In the present study, the effects of SK on NCI-H460 human lung cancer cells were investigated. It was found that SK reduced cell viability and induced apoptosis in the NCI-H460 cells. Additionally, SK inhibited extracellular signal-regulated kinase (ERK) activity, which indicates that inhibition of the ERK pathway is probably one of the mechanisms by which SK induced NCI-H460 cell apoptosis. The expression of Cbl-b was significantly increased by treatment with SK for 4 h, and gradually increased to a maximal level at 24 h; the time taken for the upregulation of Cbl-b protein was in accordance to that required for the downregulation of phospho (p)-ERK protein. The Cbl inhibitor Ps341 reversed the SK-induced downregulation of p-ERK and apoptosis of NCI-H460 cells. These results indicate that Cbl-b potentiates the apoptotic action of SK by inhibiting the ERK pathway in lung cancer cells.

References

Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
Jun 3, 2006·Journal of Cellular Physiology·Gayathri Swaminathan, Alexander Y Tsygankov
Mar 6, 2007·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Daiki MurakamiMasahide Ikeguchi
Mar 5, 2008·Molecular and Cellular Biology·Steven Pennock, Zhixiang Wang
Jan 24, 2009·International Journal of Cancer. Journal International Du Cancer·Huanjie YangJinbao Liu
Feb 6, 2010·The Journal of Biological Chemistry·Christine B F ThienWallace Y Langdon
Dec 18, 2010·Canadian Journal of Physiology and Pharmacology·Nie YingkunYu Huimin
Jan 22, 2011·Journal of Asian Natural Products Research·Hong-Ming ChengYu-Fen Zhao
Nov 3, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Benjamin WienchThomas Efferth
Jun 14, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Ting LiLiang Liu
Oct 2, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chibo LiuJiayu Chen

❮ Previous
Next ❯

Citations

Nov 13, 2013·Neuropeptides·M J Zaben, W P Gray

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
protein assay
fluorescence microscopy

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis